Companies developing a new drug product, even if it is not an NCE, should explore ways to increase the likelihood […]
Patent Term Extension for Drugs not Limited to new Chemical Entities Read Post »
The value of obtaining multiple PTEs on different patents could incentivize innovators to revise their clinical development programs This is
How to Obtain Multiple Patent Term Extensions for a Single Product Read Post »
Finding a reputable Active Pharmaceutical Ingredient (API) supplier is crucial for pharmaceutical companies to ensure the quality and efficacy of
Billions are on the table for those who can break out of the mind rubble This is a guest post
The financial risks of being found liable for patent infringement are astronomically high Developing a strategy for the development, production
There is a strong incentive to find out new opportunities for the discovery of new drugs Annual sales in the
Using drug patent information to synthesize drugs Read Post »
What is Data Exclusivity? In 1984, the USA was the first country to give legal sanctity to data exclusivity via
Drug prices are mysterious and unpredictable for many consumers With the average person’s out-of-pocket expense for a drug determined by
Deconstructing Drug Pricing Strategy for Big Pharma Read Post »
Biologic drugs are far more complex than traditional “small molecule” drugs Generic drugs as we know them differ from biosimilars, which are